This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gurgaon, IN (2014)
- Haryana, IN (2014)
Company Filing History:
Years Active: 2014
Title: Rajesh Gandhi: Innovator in Gastrointestinal Treatments
Introduction
Rajesh Gandhi is a notable inventor based in Gurugram, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable oral compositions for treating gastrointestinal disorders. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Rajesh Gandhi's latest patents include innovative formulations of stable oral benzimidazole compositions. These inventions relate to the preparation of one or more benzimidazole compounds, which are crucial for treating various gastrointestinal disorders. The processes he has developed ensure the stability and efficacy of these compositions, making them valuable in medical applications.
Career Highlights
Rajesh currently works at Ranbaxy Laboratories, Inc., a prominent player in the pharmaceutical industry. His role involves research and development, where he focuses on creating effective treatments for gastrointestinal issues. His expertise in this area has led to the successful patenting of his innovative formulations.
Collaborations
Rajesh has collaborated with several talented individuals in his field, including Chayapathy Issa and Vishnubhotla Nagaprasad. These collaborations have fostered a creative environment that encourages the development of groundbreaking solutions in pharmaceuticals.
Conclusion
Rajesh Gandhi's contributions to the field of gastrointestinal treatments through his innovative patents highlight his dedication to improving healthcare. His work at Ranbaxy Laboratories, Inc. continues to pave the way for advancements in pharmaceutical formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
